Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Naptumomab estafenatox

EU orphan designation number: EU/3/07/480   
Active ingredient: Naptumomab estafenatox
Indication: Treatment of renal cell carcinoma
Sponsor: Active Biotech AB
Scheelevägen 22, Box 724, SE-220 07 Lund, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Orphan Designation EMEA/OD/048/07 (2007)4326 of 14/09/2007
26/09/2011 Change name of sponsor EMEA/OD/048/07